Clinical Trials Browser

Phase 2 × Advanced Rare Malignant Solid Neoplasm × Tiragolumab × Clear all

NCT05715281 2025-11-25

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Phase 2 Active not recruiting

Other solid neoplasm

Advanced Rare Malignant Solid Neoplasm